either already having a strong influence on
their company’s plans, or would be in the
near future. Here’s a detailed breakdown of
Q1: How is Data-Driven Medicine
affecting your company’s products and
• 27.2% - Data-Driven Medicine is strongly influencing our plans for 2018.
• 24.5% - We have begun to factor the
requirements of Data-Driven Medicine
into our products and practices.
• 22.5% - We expect Data-Driven Medicine will influence our business in the
future but we aren’t doing much about it
• 23.8% - We don’t expect Data-Driven
Medicine will have much of an impact
Our readers were also very candid about
what they saw as the major challenges to
creating products and services that support
Data-Driven medical practices. The responses we got indicate that one of the major
frustrations was the absence of any standard
Q2: What do you see as the major
challenges to creating products and
services that support Data-Driven
• 15.7% - Most other companies and orga-
nizations we work with are not actively
involved with supporting Data-Driven
• 29.5% - Every company and organi-
zation I work with has its own set of
standards for Data-Driven Medical
• 39.0% - There are few, if any standards
that define what data is needed, how it’s
shared, and how it’s used.
• 15.1% - I can’t find any information on
Best Practices for implementing Data-Driven Medical applications.
• 29.4% - My organization is not actively
involved with Data-Driven Medicine at
We also wanted to know about the
direct impact of Data-Driven Medicine on
our readers’ jobs. Only about 41% of our respondents said that it wasn’t affecting their
job in one way or another:
Q3: How is the move towards Da-
ta-Driven Medicine affecting your job?
• 25.0% - Most or all of the new products
I will be working on will have to support
for Data-Driven Medical practices.
• 12.2% - I will be involved in retrofitting
some of my company’s existing products to support Data-Driven Medical
• 27.9% - It’s not affecting my job now, but
I expect it to in the next year.
Supporting Outcome-Based Healthcare
There is a growing consensus that part of
controlling America’s spiraling healthcare
costs is to begin to compensate healthcare providers for the outcomes they
deliver rather than the number of visits,
procedures, prescriptions, or devices
they provide. These strategies, known as
“value-based” or “outcome-based” compensation schemes will impact healthcare
providers and insurance carriers more than
the actual medical device industry, but it
will inevitably affect the products we’ll be
making. Our readers weighed in on the
issue with an overwhelming majority in
support of outcome-based strategies.
Q4: Do you think outcome-based
healthcare strategies should
have a role in the U.S. healthcare
• 81.2% - Yes
• 18.8% - No
Many of the supporters of out-
come-based payment polities drew parallels
with the evidence-based practices so suc-
cessfully used in science. As one reader put
it; “Like any engineering problem - we need
feedback from outcomes to improve systems and
treatments”. Another reader suggested; “Io T
and cloud generate real time outcome data that
must be integrated to optimize outcomes and
provide proactive control messages”.
While it was generally agreed that outcome-based policies will start to take hold
within the U.S. healthcare system, there
was much less consensus about precisely
when it would happen.
Q5: When do you think that outcome-based healthcare strategies
will begin to play a significant role
in the U.S. public healthcare system
(i.e. Medicare/Medicaid & Veterans
• 22.0% - They are already beginning to
influence how healthcare is delivered
and paid for.